TEVA
Teva Pharmaceutical Industries Ltd.
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · IL
$41.96
+0.26%Next report
Analyst consensus
- Next report date
- Jan 27, 2027
- EPS estimate
- $0.70
- Revenue estimate
- $4.3B
Latest reported
- Last report date
- Nov 3, 2026
- EPS actual
- $0.86
- EPS estimate
- $0.72
- Revenue actual
- $4.4B
- Revenue estimate
- $4.2B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 10
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- -0.5%
- Revenue beats (12Q)
- 9
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $50
- PT range
- $45 – $57
- Analysts
- 7
7 Buy0 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Nov 3, 2026 | $0.72 | $0.86 | Beat 19.44% | $4.4B |
| Jul 29, 2026 | $0.08 | $0.02 | Miss -75.00% | $4.1B |
| Apr 29, 2026 | $0.50 | $0.53 | Beat 6.00% | $4.0B |
| Jan 28, 2026 | $0.65 | $0.96 | Beat 47.69% | $4.7B |
| Nov 5, 2025 | $0.68 | $0.78 | Beat 14.71% | $4.5B |
| Jul 30, 2025 | $0.63 | $0.66 | Beat 4.76% | $4.2B |
| Jan 29, 2025 | $0.69 | $0.71 | Beat 2.90% | $4.2B |
| Jul 31, 2024 | $0.57 | $0.61 | Beat 7.02% | $4.2B |
| Jan 31, 2024 | $0.75 | $1.00 | Beat 33.33% | $4.5B |
| Nov 8, 2023 | $0.60 | $0.60 | In line | $3.9B |
| Aug 2, 2023 | $0.54 | $0.56 | Beat 3.70% | $3.9B |
| Feb 8, 2023 | $0.68 | $0.71 | Beat 4.41% | $3.9B |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Jan 27, 2027